Jefferson University Hospitals

Provider Profile

Scott A. Waldman, MD

Scott A. Waldman, MD

Academic Title: Professor
Chair, Pharmacology & Experimental Therapeutics

Specialties
Clinical Pharmacology (Not Accepting New Patients)

Office Locations

Philadelphia
132 S. 10th Street
Main Bldg., Ste 1170
Philadelphia PA 19107
Phone: (215) 955-6086
Fax: (215) 955-5681

Board Certifications

  • Internal Medicine
  • Clinical Pharmacology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Education

  • Stanford University School of Medicine, Medical School

Internship

  • Stanford University Hospital

Residency

  • Stanford University Hospital

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • CorVel
  • Geisinger Health Plan
  • HumanaChoicePPO,Medicare,GoldPlusHMO

Recent Publications

First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery

Process Improvement for Maximized Therapeutic Innovation Outcome

GUCY2C signaling opposes the acute radiation-induced GI syndrome

ST-producing E. Coli oppose carcinogen-induced colorectal tumorigenesis in mice

Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics

Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention

Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer

Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+T cells

Clinical Pharmacology & Therapeutics: Past, Present, and Future

Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum

EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates

Modeling qRT-PCR dynamics with application to cancer biomarker quantification

GUCY2C maintains intestinal LGR5+stem cells by opposing ER stress

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis

Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope

A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

Guanylyl cyclase C signaling axis and colon cancer prevention

Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer